<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Blaney</surname>
    <given-names>JE</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Sathe</surname>
    <given-names>N. S.</given-names>
   </name>
   <name>
    <surname>Goddard</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hanson</surname>
    <given-names>C. T.</given-names>
   </name>
   <name>
    <surname>Romero</surname>
    <given-names>T. A.</given-names>
   </name>
   <name>
    <surname>Hanley</surname>
    <given-names>K. A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2008</year>). 
  <article-title>Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3’-UTR with that of DENV-4.</article-title>
  <source>
   <italic>Vaccine</italic>
  </source>
  <volume>26</volume>
  <fpage>817</fpage>–
  <lpage>828</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.11.082</pub-id>
  <?supplied-pmid 18191005?>
  <pub-id pub-id-type="pmid">18191005</pub-id>
 </mixed-citation>
</ref>
